Prevalence of human T-cell lymphotropic virus-I/II-indeterminate reactivities in a Greek blood bank population [3]

Transfusion Medicine

Volumn 14, Issue 3, 2004, Pages 253-254

  Tseliou, P M ^b   Spiliotakara, A ^b   Politis, C ^c   Spanakis, N ^a   Legakis, N J ^a   Tsakris, Athanassios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^c G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BANK; BLOOD DONOR; GREECE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INFECTION RISK; LETTER; RISK ASSESSMENT; VIRAL CONTAMINATION; VIRUS TRANSMISSION; WESTERN BLOTTING;

BLOOD BANKS; BLOOD DONORS; DELTARETROVIRUS INFECTIONS; DISEASE NOTIFICATION; GREECE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MASS SCREENING; PREVALENCE; TRUTH DISCLOSURE;

EID: 3042595889     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0958-7578.2004.00509.x     Document Type: Letter

References (7)

1. Busch, M.P., Switzer, W.M., Murphy, E.L., Thomson, R. & Heneine, W. (2000) Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results. Transfusion, 40, 443-449.
2. Morozov, V.A., Ellerbrok, H., Fleischer, C., Brackmann, H.H. & Pauli, G. (2002) Defective human T-cell leukaemia virus type 1 (HTLV-1) genomes: no evidence in serologically indeterminate german blood donors but new type detected in established cell lines. Journal of Medical Virology, 66, 102-106.
3. Remesar, M., Mangano, A., Sen, L. & del Pozo, A. (2002) Profile of human T-cell lymphocytotrophic virus-I/II infections in an Argentinean blood population. Vox Sanguinis, 83, 364-365.
4. Rouet, F., Meertens, L., Courouble, G., Herrmann-Storck, C., Pabingui, R., Chancerel, B., Abid, A., Strobel, M., Mauclere, P. & Gessain, A. (2001) Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I gag indeterminate western blot patterns from the Caribbean. Journal of Clinical Microbiology, 39, 1247-1253.
5. Thorstensson, R., Albert, J. & Andersson, S. (2002) Strategies for diagnosis of HTLV-I and -II. Transfusion, 42, 780-791.
6. Tseliou, P.M., Spanakis, N., Spiliotakara, A., Politis, C., Legakis, N.J. & Tsakris, A. (2003) HTLV-I and -II in southwestern Greece. Transfusion, 43, 1641-1642.
7. Vrielink, H., Sisay, Y., Reesink, H.W., Woerdeman, M., Winkel, C., de Leeuw, S.J., Lelie, P.N. & van der Poel, C.L. (1995) Evaluation of a combined lysate/recombinant antigen anti-HTLV-I/II ELISA in high and low endemic areas of HTLV-I/II infection. Transfusion Medicine, 5, 135-137.